2010Yiyao daobaoRequires access

Curative Effect of Bifid Triple Viable Bacteria Capsules Combined with Trimebutine Maleate Tablets in Treating Diarrhea Irritable Bowel Syndrome

Emily W. H. Tang

Open publisher page 0 citations

Abstract

Objective To investigate the curative effect of bifid triple viable bacteria capsules combined with trimebutine maleate tablets on the treatment of diarrhea irritable bowel syndrome. Methods 75 patients with diarrhea irritable bowel syndrome were divided into two groups: 38 patients of treatment group treated with trimebutine maleate tablets,0. 2 g,tid, po and bifid triple viable bacteria tablets,40 mg,bid,po,37 patients of control group treated with trimebutine maleate tablets in the same therapeutic way. The clinical symptom of two groups was compared before and after treatment,respectively,and clinical efficacy was evaluated after treatment. Results The symptoms of treatment group were significantly improved than the control group. The total effective rate of it ( 92. 11% ) was higher than that of the control ( 81. 08% ) ,P 0. 05. Conclusion The treatment of bifid triple viable bacteria tablets combined with trimebutine maleate tablets can provide a satisfactory effect for patients with diarrhea irritable bowel syndrome.

About this research paper

What this paper is about

Objective To investigate the curative effect of bifid triple viable bacteria capsules combined with trimebutine maleate tablets on the treatment of diarrhea irritable bowel syndrome. Methods 75 patients with diarrhea irritable bowel syndrome were divided into two groups: 38 patients of treatment group treated with trimebutine maleate tablets,0. 2 g,tid, po and bifid triple viable bacteria tablets,40 mg,bid,po,37 patients of control group treated with trimebutine maleate tablets in the same therapeutic way. The clinical symptom of two groups was compared before and after treatment,respectively,and clinical efficacy was evaluated after treatment. Results The symptoms of treatment group were significantly improved than the control group. The total effective rate of it ( 92. 11% ) was higher than that of the control ( 81. 08% ) ,P 0. 05. Conclusion The treatment of bifid triple viable bacteria tablets combined with trimebutine maleate tablets can provide a satisfactory effect for patients with diarrhea irritable bowel syndrome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the curative effect of bifid triple viable bacteria capsules combined with trimebutine maleate tablets on the treatment of diarrhea irritable bowel syndrome. Methods 75 patients with diarrhea irritable bowel syndrome were divided into two groups: 38 patients of treatment group treated with trimebutine maleate tablets,0. 2 g,tid, po and bifid triple viable bacteria tablets,40 mg,bid,po,37 patients of control group treated with trimebutine maleate tablets in the same therapeutic way. The clinical symptom of two groups was compared before and after treatment,respectively,and clinical efficacy was evaluated after treatment. Results The symptoms of treatment group were significantly improved than the control group. The total effective rate of it ( 92. 11% ) was higher than that of the control ( 81. 08% ) ,P 0. 05. Conclusion The treatment of bifid triple viable bacteria tablets combined with trimebutine maleate tablets can provide a satisfactory effect for patients with diarrhea irritable bowel syndrome.

Key concepts: Irritable bowel syndrome, Diarrhea, Medicine, Gastroenterology, Internal medicine, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Curative Effect of Bifid Triple Viable Bacteria Capsules Combined with Trimebutine Maleate Tablets in Treating Diarrhea Irritable Bowel Syndrome — Research Paper | ScholarLens